… of 6 months has been reported, which was increased to 12 months by treatment with 5-FU …
combination with leucovorin, decreased toxicity and increased efficacy of 5-FU treatment. The …

… in colorectal cancer treatment. From the late 1950s until very recently, fluorouracil (FU) was
the only drug approved for the treatment of colorectal cancer. … toxicity and increased efficacy, …

… immunogenicity in metastatic colorectal cancer is needed in … in the context of metastatic
colorectal cancer. We summarize the … in an increased risk of developing several types of cancer, …

… failed to demonstrate significant differences of efficacy. Minor differences were … efficacy and
toxicity of the first-line treatment with FOLFOXIRI in metastatic unresectable colorectal cancer …

… to chemotherapy was associated with statistically significant increases in overall survival (OS;
HR… perforations, and thromboembolic events were increased with bevacizumab treatment. …

… colorectal cancer and increasing cure rates among those with resectable disease. … Oaks,
CA), have definitively shown efficacy in colorectal cancer (Table 3). Although small molecule …

… with CAPIRI that compromised CAPIRI's efficacy and increased its toxicity. A further large …
Further development in alterative dosing schedule of CAPIRI could provide a better efficacy …

… in increasing self-efficacy and quality of life, and decreasing symptom distress in
colorectal cancer … the hypothesis that colorectal cancer patients who received self-efficacy-enhancing …

… The addition of EGFR MAb to either chemotherapy or best supportive care improves
progression-free survival, overall survival and tumour response rate, but may increase toxicity in …

… We conclude that α-IFN does not increase the efficacy of 5FU … + LV, for patients with advanced
colorectal cancer. © 2001 … not increase the efficacy of 5FU in advanced colorectal cancer…